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ABSTRACT 
In vitro and ex vivo substrate stiffness effects on endothelial monolayer permeability in 
response to TNF-α. 
Christina Maria Furia 
Alisa Morss Clyne, Ph.D. 
 
Hypertension affects 67 million American adults and is a major risk factor for 
atherosclerosis. While hypertension was once thought to lead to adaptive vascular stiffening, 
recent studies suggest that reversible vascular stiffening precedes hypertension development. In 
addition, increased inflammation, such as elevated inflammatory cytokine tumor necrosis factor-
α (TNF-α), is associated with hypertension. 
 Both stiff substrates and TNF-α increase endothelial cell permeability, which contributes 
to atherosclerotic plaque development; however, the impact of substrate stiffness on endothelial 
cell permeability with TNF-α has not previously been investigated. In this project, we developed 
an assay to measured endothelial cell permeability with TNF-α on different stiffness 
polyacrylamide (PA) gels. We also created an ex vivo tissue chamber to enable en face 
fluorescent imaging of live mouse aortae for real time quantification of endothelial cell 
permeability in intact vessels exposed to flow. Our data confirms the increase in permeability 
with TNF-α treatment and substrate stiffness and suggests an interaction between inflammation 
and stiffness on endothelial cell permeability. 
This research enhanced our understanding of the integrated impact of substrate stiffness 
and inflammatory molecules on endothelial barrier loss. This can lead to a greater understanding 
of how hypertension contributes to atherosclerosis.  By improving our knowledge of the 
interactions between biomechanical and biochemical stimuli, we can develop targeted 
hypertension therapies. 
 
  
 
 
1. INTRODUCTION 
1.1 Clinical Relevance  
Hypertension is clinically defined as chronic elevated blood pressure of over 140 mm Hg 
systolic or 90 mm Hg diastolic (Crim et al., 2012). Hypertension is a prevalent condition 
currently affecting 31% of American adults, equating to 67 million people (Centers for Disease 
& Prevention, 2011). An additional third of American adults are classified as pre-hypertensive, 
which means they are currently at high risk for developing hypertension (Centers for Disease & 
Prevention, 2011). In 2013, high blood pressure was the primary or contributing cause in an 
estimated 360,000 deaths (Centers for Disease & Prevention, 2011). Hypertension is a major risk 
factor for cardiovascular disease and increases mortality from stroke and ischemic heart disease 
two fold (Crim et al., 2012). In the United States alone, hypertension was estimated to cost $46 
billion per year which includes both direct and indirect costs (Centers for Disease & Prevention, 
2011). Hypertension annual cost is projected to increase to $200.3 billion by 2030 (Heidenreich 
et al., 2011). These data underscore the importance of preventing and treating this disease to 
reduce the associated costs as well as the morbidity and mortality rates.  
Hypertension is associated with increased vascular stiffness. Coutinho et al. has shown 
that arterial stiffness is directly correlated to an increase in mean, systolic and pulse pressure in 
treated hypertensive patients over a mean period of 8.5 years (Coutinho, Bailey, Turner, & 
Kullo, 2014). Previously, conventional thinking suggested that hypertension stimulates 
irreversible arterial remodeling and stiffening as a response to increased hemodynamic forces on 
the arterial wall (Weisbrod et al., 2013). However, it has more recently been shown that 
potentially reversible arterial stiffening precedes an increase in systolic blood pressure in patients 
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participating in the Framingham Heart Study (Kaess et al., 2012). A mouse model of diet-
induced obesity has shown that arterial stiffening, as measured by pulse wave velocity, precedes 
the hypertension onset (Weisbrod et al., 2013). In addition, this initial increase in arterial 
stiffening was reversible once the mice were returned to a normal diet (Weisbrod et al., 2013).  
Hypertension is also associated with inflammation. In healthy middle aged men, a 
significant linear relationship between blood pressure and inflammatory marker (sICAM-1 and 
IL-6) levels was established (Chae, Lee, Rifai, & Ridker, 2001). According to the ATTICA 
Study, pre-hypertensive patients showed a 32% increase in the inflammatory cytokine tumor 
necrosis factor-α (TNF-α) compared to normotensive patients (Chrysohoou, Pitsavos, 
Panagiotakos, Skoumas, & Stefanadis, 2004). In an animal model, Tran et al. showed that 
treatment with etanercept, a competitive TNF-α inhibitor, in rats fed with a high fructose diet 
prevented the hypertension development seen in untreated controls (Tran, MacLeod, & McNeill, 
2009). Irreversible structural changes in the vessel walls are not thought to develop until another 
stimulus such as elevated inflammation occurs (Savoia et al., 2011). This then signals vascular 
remodeling which induces extracellular matrix deposition and smooth muscle cell proliferation, 
causing the lumen reduction while increasing the vessel’s medial width (Savoia et al., 2011). 
A direct relationship between increases in arterial stiffening (measured by pulse wave 
velocity and augmentation index) and circulating levels of inflammatory cytokines (IL-4 and 
TNF-α) have been shown in hypertensive patients (Mahmud & Feely, 2005). While both 
vascular stiffness and inflammation are associated with hypertension, their interactions had not 
yet been examined. The objective of this thesis is to determine how vascular stiffness and 
inflammation may interact, thereby leading to increased hypertension and cardiovascular disease.  
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1.2 The Endothelium as a Permeability Barrier 
Endothelial cells line the entire vascular system (Alberts, Johnson, Lewis, & al., 2002). 
These cells form a selective semi-permeable barrier and play a crucial role in regulating vascular 
structure and function, including angiogenesis, permeability, vascular tone, and hemostasis 
(Alberts et al., 2002). Endothelial dysfunction both leads to and is a result of hypertension 
(Dharmashankar & Widlansky, 2010). The Framingham Heart Study established a direct 
correlation between cardiovascular risk factors such as hypertension and the degree of 
endothelial impairment in human patients measured by flow mediated dilation of the brachial 
artery (Benjamin et al., 2004). However, whether this dysfunction is a cause or an effect of 
hypertension still remains unclear (Dharmashankar & Widlansky, 2010). Disruption of 
endothelial function, specifically permeability, can contribute to cholesterol accumulation in the 
arterial wall and subsequent atherosclerotic plaque development (Poredos, 2001).  
 Endothelial permeability is regulated by cell-cell junctions. There are three types of 
intercellular junctions: gap junctions, tight junctions, and adherens junctions. Gap junctions 
mediate cell-to-cell communication by allowing small molecular weight solutes to pass between 
neighboring cells. Tight junctions restrict both fluid diffusion across intercellular spaces and 
solutes across plasma membranes by regulating paracellular permeability and maintaining cell 
polarity. Adherens junctions play an important role in contact inhibition of endothelial cell 
growth, as well as paracellular permeability to circulating leukocytes and large solutes (Bazzoni 
& Dejana, 2004). Adherens junctions also provide mechanical strength by connecting the plasma 
membrane of adjacent cells to the actin cytoskeleton (Garcia, Ducheyne, & Boettiger, 1997). 
Vascular endothelial (VE) cadherin is an endothelial cell specific cadherin and is the most 
prominent cadherin at the adherens junctions. VE-cadherin binds to β-catenin via a C-terminal 
4 
 
domain and recruits α-catenin to connect the complex to the actin cytoskeleton (Garcia et al., 
1997). Thrombin, a serine protease involved in the coagulation cascade, increases endothelial 
permeability through the disruption of cell-cell junctions, resulting in intercellular gap formation 
(Rabiet et al., 1996). Binding of thrombin to its receptor, proteinase-activated resceptor (PAR), 
activates G-proteins which decrease cyclic adenosine monophosphate (cAMP), increase Ca2+ and 
diacylglycerol concentrations and activate Rho within the cell (Bogatcheva, Garcia, & Verin, 
2002). Thrombin-induced permeability is mediated via myosin light chain (MLC) 
phosphorylation and myosin II interacting with F-actin through Rho associated-kinase (ROCK) 
and myosin light chain kinase (MLCK) leading to increased contractility (Bogatcheva et al., 
2002). Stabilizing VE-cadherin-actin interactions through the use of fusion proteins has been 
shown to protect endothelial barrier function from thrombin or vascular endothelial growth factor 
induced hyperpermeability (Garcia et al., 1997).  
 
1.3 Endothelial Cell Response to Substrate Stiffness 
Tissue stiffness varies widely throughout the body. Solid tissue stiffness ranges from 1 
kPa in organs such as the brain to 100 kPa in organs such as bone with muscle tissue in the 10 
kPa range (Zajac & Discher, 2008). In culture, cells are commonly seeded on surfaces such as 
glass and plastic, which are stiff compared to the physiologically relevant tissue (Yeung et al., 
2005). Endothelial cells spread and proliferate by first attaching to a substrate. Recently, 
substrate stiffness has been shown to affect many cell behaviors in vitro, including cell 
spreading, adhesion, migration and differentiation (Discher, Janmey, & Wang, 2005); (Pelham & 
Wang, 1997); (Zaman et al., 2006); (Engler, Sen, Sweeney, & Discher, 2006).  
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Polyacrylamide gels of varying stiffnesses have been used to show that normal rat kidney 
epithelial cells and Swiss 3T3 fibroblast cells can sense the substrate stiffness in an integrin and 
myosin dependent manner (Pelham & Wang, 1997). Softer substrates altered cell morphology 
and increased motility while decreasing focal adhesion stability (Pelham & Wang, 1997). When  
Matrigel concentration was used to alter substrate stiffness, prostate cancer cells (DU-145) 
decreased migration speed with increased stiffness and further decreased speed with integrin 
inhibition (Zaman et al., 2006). Mesenchymal stem cells also respond to the stiffness of the 
microenvironment through differentiation (Engler et al., 2006). These cells sprout neuron-like 
dendrites when seeded on soft substrates (0.1-1 kPa) that mimicked brain tissue, formed spindle 
shaped cells similar to myocytes on gels with elasticity in the muscle range (8-17 kPa), and 
produced a morphology similar to osteoblasts on stiffer gels (25-40 kPa) (Engler et al., 2006).   
Paracellular endothelial permeability is controlled in part by the endothelial cell-cell 
junctions, which are directly affected by interactions between endothelial cells and substrates 
(Dejana, Orsenigo, & Lampugnani, 2008). Reinhart-King et al. demonstrated that 0.5 to 33 kPa 
polyacrylamide gels alter bovine aortic endothelial cell (BAEC) cell-cell interactions, including 
migratory behavior and extension frequency. These interactions are directly linked to monolayer 
integrity and permeability, showing that stiffer substrates are more likely to induce breaks in 
cell-cell contact (Reinhart-King, Dembo, & Hammer, 2008). Using traction force microscopy on 
polyacrylamide gels (1.2 to 11 kPa), it has been shown that human umbilical vein endothelial 
cells (HUVECs) exert greater forces on both the surrounding cells and the substrate when on 
substrates of greater stiffness (Krishnan et al., 2011).  In addition, the ability for these cells to 
pull apart was reduced on softer substrates, demonstrated by the reduction in gaps formed from 
thrombin treatment on the softer gels (Krishnan et al., 2011).   
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More recently, Huynh et al. showed that substrate stiffness can impact endothelial cell 
permeability. BAEC were seeded on polyacrylamide gels of different stiffness (2.5 to 10 kPa), 
and monolayer permeability was quantified using fluorescently labeled dextran. Stiffer substrates 
increased endothelial monolayer permeability because increased cell contractility mechanically 
disrupted cell-cell junctions (Huynh et al., 2011).  In addition, permeability of stiffer thoracic 
aortas from aged mice was compared to permeability of more compliant aortas from young mice 
using an Evans Blue Assay. These data demonstrated that permeability increased with aging in 
vivo. A ROCK inhibitor (Y-27632) was also used to suppress these effects, demonstrating that 
the permeability increase was a result of cell contractility from the Rho pathway. This article also 
showed that matrix stiffening promotes leukocyte transmigration, which further supports the 
increase in monolayer permeability and may be a crucial contributor to atherosclerotic plaque 
formation (Huynh et al., 2011). 
 
1.4 Tumor Necrosis Factor-α (TNF-α) and Endothelial Cell Permeability 
Tumor necrosis factor-α (TNF-α) is one of many soluble factors involved in 
inflammation (Zhang et al., 2009). When foreign agents enter the body during infection or 
implantation, immune cells in the area release TNF-α to chemically stimulate macrophage and 
leukocyte accumulation at the inflammation site (Young, Ye, Frazer, Shi, & Castranova, 2001). 
However, increased inflammatory cytokine levels have been shown to decrease nitric oxide 
levels, reducing smooth muscle relaxation and thereby increasing vascular resistance (Zhang et 
al., 2009).  
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McKenzie and Ridley reported TNF-α induced changes in F-actin organization, tight 
junction protein distribution and permeability through Rho/ROCK and MLCK signaling 
pathways in human umbilical vein endothelial cells (HUVEC) (McKenzie & Ridley, 2007). This 
was measured on fibronectin coated glass coverslips using ROCK inhibitor Y-27632, Rho 
inhibitor C3 transferase and MLCK inhibitor ML-7 (McKenzie & Ridley, 2007). TNF-α also 
causes actin stress fiber formation and cell contraction through the Rho/ROCK pathway. This 
increased monolayer permeability through the loss of cell-cell junctions in HUVEC on glass 
coverslips (Wojciak-Stothard, Entwistle, Garg, & Ridley, 1998). TNF-α can facilitate 
atherosclerotic plaque formation by increasing the expression of endothelial cell adhesion 
molecules, increasing endothelial cell leakiness and inducing smooth muscle cell proliferation 
(Wojciak-Stothard et al., 1998).  
 
1.5 Biochemical and Biomechanical Cross-talk: TNF-α and substrate stiffness 
A combination of early reversible vascular stiffness and TNF-α may lead to long-term 
arterial stiffening via vascular remodeling. Both stiff substrates and TNF-α have been shown to 
alter endothelial cell permeability; however, the impact of substrate stiffness on endothelial cell 
integrity has only been briefly investigated in combination with TNF-α. Stroka and Aranda-
Espinoza investigated the effects of TNF-α and substrate stiffness on neutrophil transmigration 
through human umbilical vein endothelial cells on substrates of different stiffness (0.42 to 280 
kPa) (Stroka & Aranda-Espinoza, 2011). The results showed that increased substrate stiffness (5 
and 280 kPa compared to 0.87 kPa)  increased neutrophil transmigration and formed large holes 
in the endothelial monolayers treated with TNF-α (Stroka & Aranda-Espinoza, 2011). Without 
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TNF-α treatment, low transmigration was detected in all stiffnesses (Stroka & Aranda-Espinoza, 
2011). Additionally, the myosin light chain kinase (MLCK) inhibitor ML-7 significantly reduced 
transmigration on stiff substrates, demonstrating that the permeability increase may be due to 
changes in cell-cell adhesion through MLCK-dependent cell contractility (Stroka & Aranda-
Espinoza, 2011). 
 
1.6 Thesis Goal 
The endothelial cell biomechanical environment influences cell response to biochemical 
stimuli. Endothelial cell exposure to inflammatory molecules, such as TNF-α, increases cell 
monolayer permeability (McKenzie & Ridley, 2007). In addition, stiffer substrates also increase 
cell permeability (Huynh et al., 2011). However, the interactions between substrate stiffness and 
inflammatory cytokines have not been previously investigated in depth.  I hypothesized that 
endothelial cell monolayer permeability increases more on stiff substrates compared to soft 
substrates in response to TNF-α. To investigate this hypothesis, I completed the following 
aims: 
 
Aim 1:  Design and test an ex vivo system enabling en face testing of mouse aorta permeability 
under flow conditions. 
 Current ex vivo systems that enable vascular permeability measurements under 
physiological flow conditions involve complex blood vessel cannulation systems and are only 
adequate for imaging thin vessels. Simple, inexpensive parallel plate flow chambers have been 
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used extensively to apply shear stress to endothelial cell monolayers to model physiologically 
relevant conditions in vitro. There is a need for a tissue flow chamber which enables real time 
fluorescent imaging of larger vessels. I designed and built a tissue chamber to allow for en face 
imaging of the endothelial layer of a mouse thoracic aorta while applying physiologically 
relevant shear stress. Through this device, we can directly observe endothelial cell in situ 
response to biochemical stimuli under physiologically relevant shear stress conditions.  
 
Aim 2:  Quantify TNF-α-induced changes in endothelial cell monolayer permeability in vitro 
on substrates of different stiffness. 
 In vitro studies provide a higher level of experimental control and allow for easier 
measurement and manipulation of molecular pathways. To explore the combined effects of 
biomechanical and biochemical stimuli on endothelial cell barrier function, permeability was 
evaluated in vitro by assessing endothelial cell response to substrate stiffness and TNF-α. 
Endothelial monolayers were cultured on polyacrylamide gels of defined stiffnesses and then 
treated with TNF-α. Permeability was assessed by measuring the transport of fluorescently 
labelled Dextran molecules through an endothelial monolayer and into the gel.  
 Although the simplified in vitro model of endothelial permeability does allow for a high 
level of experimental control, it may not take into account all of the factors associated with the in 
vivo condition. The ex vivo tissue flow chamber can be used to confirm the results of the in vitro 
assay in a more physiologically relevant environment with a greater level of control over other 
variables.  
 
10 
 
This research enhanced our understanding of the impact substrate stiffness and 
inflammatory molecules have on endothelial barrier loss. This can lead to a greater 
understanding of how endothelial dysfunction in hypertension contributes to cardiovascular 
diseases such as atherosclerosis.  By improving our knowledge of the interactions between 
biomechanical and biochemical stimuli, we can develop more effective hypertension therapies.  
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2.   DESIGN OF EX VIVO FLOW CHAMBER 
2.1 Introduction 
2.1.1 Ex Vivo Motivation 
While in vitro studies may provide a higher level of experimental control, they do not 
take into account the effect of complex interactions among different cell types and matrix 
proteins found in actual blood vessels (Rezvan, Ni, Alberts-Grill, & Jo, 2011). In vivo models 
allow the tissue to remain in its physiologically relevant environment; however, the complexity 
of this system leads to a greater chance of confounding variables. Ex vivo models are used to 
bridge the gap between these two approaches. This provides us with the motivation to develop an 
ex vivo system to allow for real time fluorescent imaging of the native endothelium of a mouse 
aorta to assess the response of biomechanical and biochemical stimuli in a more controlled 
environment.      
 
2.1.2 Current Ex Vivo Techniques 
Current ex vivo techniques fall into three general categories: vessel cannulation and 
perfusion, muscle chambers and en face imaging. Direct real-time imaging of the endothelial 
layer using cannulation and perfusion techniques is most commonly done on smaller vessels. 
This requires isolating the vessel from the animal, cannulating the vessel on a double pipette 
system, controlling external and internal temperature and pressure of the vessel and in some 
cases applying shear stress through perfusion (Duling, Gore, Dacey, & Damon, 1981); (Van 
Epps, Chew, & Vorp, 2009); (Kirsch et al., 2013); (Yen, Cai, Zeng, Tarbell, & Fu, 2012). The 
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double pipette system used in this cannulation method allows the tissue to be adjusted easily in 
the culture chamber to account for different vessel segment lengths and position within the 
imaging system. Using a confocal microscope, this set up is adequate for imaging the internal 
endothelial layer with the vessel intact as long as the vessel has few smooth muscle cell layers 
and no branching. If the smooth muscle cell layer is thick, as is the case in larger arteries, the 
microscopic resolution is greatly decreased. Also, any branching or disruption in the tissue can 
cause fluid leakage and a loss of internal pressure.  
Muscle chambers, which are used to apply stimuli and monitor the response of muscle 
tissue, have been adapted to accommodate vascular tissue. These are used to examine strips or 
rings of vascular tissue and observe the tissue’s contractile response to drugs, electrical stimuli 
and mechanical stress (Furchgott & Bhadrakom, 1953); (Nausch et al., 2012); (Metzler, Digesu, 
Howard, To, & Warnock, 2012). However, these techniques are not capable of measuring the 
response of the endothelium directly and rely on gross measurements of changes in tissue 
dimensions to gauge smooth muscle cell contractility as a response to factors released by the 
endothelium. This indirect measurement of endothelial function is not a reliable measurement for 
permeability. One unique ex vivo vessel assembly assessing permeability was found which used 
a custom designed tissue holding device in conjunction with well assemblies to apply segments 
of shear stress to the vessel (Fry, 2002). However, this set up was designed for swine arteries 
which are much larger than the mouse vessels more commonly used.   
 En face, which is translated as having face or front forward, is a term to describe the 
direct exposure of endothelial cell layers. (Walpola, Gotlieb, Cybulsky, & Langille, 1995). This 
technique consists of longitudinally cutting the vessel, fixing and mounting the tissue on a cover 
slip for imaging as previously described (Gaudreault, Scriven, & Moore, 2004). En face imaging 
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techniques provide a means to image the structure of the endothelium; however, it is currently 
primarily used for imaging fixed vessels.    
 
2.1.3 Current In Vitro Techniques 
 Applying shear stress to the endothelium places the tissue in a more physiologically 
relevant setting. Currently the effects of shear stress on individual endothelial cells and 
endothelial monolayers are studied in vitro using techniques such as cone and plate viscometers, 
microfluidic devices and parallel plate flow chambers. The cone and plate viscometer consists of 
a rotating cone over a stationary disc which ideally produces a uniform shear field on the 
cultured cells underneath the cone (Spruell & Baker, 2013). For our purposes, adaption of a cone 
and plate viscometer for use with ex vivo vessel preparations is not feasible. The circular 
morphology of the disc is not compatible with the rectangular shape of the opened blood vessel 
and is unable to apply shear stress longitudinally down the center of the tissue to simulate 
physiologically relevant flow conditions. In addition, the motors needed to run these devices are 
bulky which could complicate imaging.  
Microfluidic devices are also used to study the effect of shear stress on endothelial cells 
in vitro.  These devices consist of micrometer sized channel systems etched or molded into a 
material (usually glass, silicon or polymers like polydimethelsiloxane) using microfabrication 
techniques which allows for shear stress to be applied to cells cultured within the channels 
(Rezvan et al., 2011). They are useful in reducing the amount of media and reagents used and 
model the vascular structures found in the body (Rezvan et al., 2011). However, it would be very 
14 
 
difficult to incorporate ex vivo vascular tissue preparations into these small structures. Thus, the 
use of microfluidic devices was eliminated as an option for this application.  
Lastly, parallel plate flow chambers are widely used to apply shear stress to endothelial 
cells in vitro. This device typically consists of a top outer chamber separated by a silicon gasket 
from a glass coverslip seeded with cells (Rezvan et al., 2011). The parallel plate flow chamber 
applies a constant surface shear stress to cells along a linear path from the inlet to the outlet port 
(Rezvan et al., 2011). The gasket thickness determines the height of the flow path, altering shear 
forces exerted on the cells. This system can be constructed out of an optically transparent 
material which allows cell layers to be easily observed and imaged. One disadvantage to this 
system is that a peristaltic pump produces unsteady flow through the chamber which causes more 
complex flow patterns.   
A SWOT analysis was used to evaluate the three current in vitro methods of applying 
shear stress (Table 2.1). It was determined that parallel plate flow chamber design has the most 
potential to be adapted to apply shear stress to blood vessels ex vivo.  
Table 2.2. SWOT analysis of the current methods used to examine the effects of shear stress to 
cells in vitro. 
 Strengths Weaknesses Opportunities Threats 
Cone and 
Plate 
Viscometer 
Large size to allow 
for increased number 
of cell populations 
Circular 
Morphology 
Flow pattern 
Shear stress 
variations 
Adherence to disc 
Microfluidic 
Device 
Conservation of 
media and reagents 
Too small to 
adapt to 
tissue 
Model vascular 
structures in the 
body 
Complex process 
used to make 
device 
Parallel 
Plate Flow 
Chamber 
Flow patterned 
directed 
Flow easily observed 
Peristaltic 
flow pump 
 
Technique already 
used in lab 
Isolated system 
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2.1.4 Advantages of New Design 
 This new flow chamber design will allow for the direct imaging of endothelial cell 
monolayers on intact, large vessel tissue such as the mouse aorta while under physiologically 
relevant flow conditions. This will provide a tool to better understand the complex relationship 
between endothelial monolayers and their response to both chemical and mechanical stimuli 
within the intact tissue structure.  
 
2.2 Problem Statement 
Currently, there is no system available to image endothelial cells directly in larger vessels 
under shear stress to gauge their response to mechanical and chemical manipulation ex vivo. The 
current strategy for ex vivo vessel imaging is adequate for small intact vasculature; however the 
addition of smooth muscle cell layers in larger tissue such as the aorta corrupts image quality 
within the vessel. Additionally, to look at the tissue in a more physiologically relevant 
environment and to see the effects of shear stress on the cells, a device is needed to allow for 
flow induction on the endothelial layer.     
 
2.3 Design Parameters 
2.3.1 Design Objective 
The objective of this design is to create a device which will allow for direct real time 
fluorescent imaging of endothelial cells in larger vessels while applying a shear stress to the 
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tissue endothelium. This system is needed to allow for a visual measurement of endothelial 
permeability through the use of fluorescently labeled molecules.    
 
2.3.2 Constraints: 
 Shear Stress of up to 20 dynes/cm2 
 Laminar Flow (Re < 2000) 
 Maximum Internal Chamber dimensions: ~2mm x 10mm 
 Secure Tissue Fixation for up to 12 hours  
 Endothelial and Vascular Smooth Muscle Cell Survival  (viability >90%) for up to 12 
hours 
 Waterproof Seal  
 Compatible with Fluorescent Microscopy  
 
The justification for the constraints and criteria chosen: 
A maximum constant shear stress of 20 dynes/cm2 was chosen because it is a 
physiologically relevant shear stress that results in endothelial cell flow adaptation. The chamber 
shear stress was determined using Equation 1. 
Equation 1.                                                           𝜏 =
6𝑄𝜇
𝑏ℎ2
 
In this equation, Q is the fluid flow rate through the chamber, b and h are the width and 
the height of the chamber flow path respectively and µ is the fluid viscosity. In these 
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calculations, µ was estimated as the dynamic viscosity of water at 37°C. b was selected to be 
smaller than the mouse thoracic aorta. Q and h were adjusted appropriately to be able to apply a 
shear stress of 20 dynes/cm2 without having too high of a flow rate.  
Laminar flow was chosen to produce the simplest flow pattern to analyze the effects of 
shear stress. In addition, turbulent flow can disrupt the cell layer and cause unwanted effects. 
Laminar flow can be described by calculating the Reynold’s number less than 2000. This was 
determined through the use of Equation 2. 
Equation 2.                                                           𝑅𝑒 =  
𝑄
𝑣𝑏
 
In this equation, Q is the fluid flow rate through the chamber, v is the kinematic viscosity 
and b is the chamber width. 
A longitudinally cut mouse thoracic aorta was measured to be approximately 2mm wide 
and between 9mm and 12mm long (Figure 2.1). The maximum internal chamber dimensions 
must be smaller than the tissue dimensions to maintain a seal between the chambers.  
 
Figure 2.1.  Mouse aorta size was used for chamber dimensions (dashed box). (a) Mouse 
thoracic aorta width (cut and flattened) used for internal chamber width (~2mm). (b) Maximum 
mouse thoracic aorta length used for internal chamber length (~12mm). 
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The ability to maintain secure tissue fixation and maintain cell survival for up to 12 hours 
was determined since current experiments to evaluate the effects of substrate stiffness and TNF-α 
on endothelial permeability last for up to 6 hours. Since 6 hours is the maximum time point 
assessed, 12 hours of fixation and cell viability will provide an adequate window to confirm 
healthy cells during experimentation. 
Maintaining a waterproof seal is important during design considerations to limit fluid 
flow disruption and to protect the microscope from fluid damage.  
To allow for live imaging of the endothelial layer the chamber must be compatible with 
Live Fluorescent Microscopy which means it must be transparent (UV light permissible), it must 
not autofluoresce and it must maintain physiologically relevant tissue temperatures. In addition, 
the chamber should be thin enough to allow for imaging the vessel on a microscope.  
 
2.4 Conceptual Design and Alternatives 
 Many design alternatives were considered in the tissue flow chamber design. The main 
design consideration was how to secure the tissue in an en face configuration within the 
chamber. A decision matrix was used to determine the best initial design idea which can be 
found in Table 2.2.  
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Table 2.2. A decision matrix to determine the best choice for securing the tissue in the chamber. 
Constraints (Weight) Glue Hooks Magnet Pin PDMS Screw Gasket 
Cost (2) 1 2 2 3 2 
Ease of Fabrication (2) 1 2 2 1 3 
Laminar Flow (3) 2 3 3 1 1 
Ease of Assembly (3) 1 2 3 2 2 
Flatten Vessel (3) 1 2 3 2 2 
Waterproof Seal (1) 2 1 2 3 3 
Cell Survival (3) 1 2 3 2 2 
Totals 21 36 46 32 34 
The justifications for the numbers provided in the device decision matrix: 
 
Cost - weight of a 2 because it would not be practical for the device to be ridiculously expensive: 
1- Not reusable and therefore all material must be continuously purchased 
2- Reusable but material must be initially purchased 
3- Reusable and material is available   
Ease of Fabrication – weight of a 2 because it is moderately important to be able to accurately 
make the device for use.  
1- Parts that have to be hand set and dry 
2- Parts that have to be hand set but are adhered once placed 
3- Parts that can all be machined 
Laminar Flow – weight of a 3 because it can greatly affect cell response to shear stress  
1- Likely to disturb flow 
2- Unlikely to disturb flow 
3- Definitely will not disturb flow 
Ease of Assembly – weight of a 3 because it is important for experiments to be easily prepared 
1- Must be manually applied  
2- Must be manually aligned 
3- Automatically aligns 
Flatten Vessel – weight of a 3 because it is important to not disrupt flow and have level imaging 
field  
1- Unlikely to maintain flat vessel 
2- Likely to maintain flat vessel 
3- Definitely will maintain flat vessel 
Waterproof Seal – weight of a 1 because while it is important to maintain flow in chamber small 
leaks can be combated with an outside chamber to protect microscopes 
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1- Difficult to seal 
2- Applies seal which may not be fully waterproof 
3- Ensures good waterproof seal  
Cell Survival – weight of a 3 because cells must be maintained for accurate results 
1- May disrupt tissue chemically 
2- May disrupt tissue physically 
3- Does not disrupt tissue  
Fluorescence – weight of a 3 because this is needed to detect endothelial response  
 Not listed because all chambers can be made from cast acrylic commonly used in 
imaging. 
 
From the decision matrix it was determined that magnets would be one of the best ways 
to adhere the tissue inside the chamber. This was primarily because magnets are reasonably 
inexpensive, provide ease of use and can be imbedded inside the chamber so as to not disrupt 
flow. Also, the force applied on the tissue can be adjusted depending on magnet selection. 
However, the use of magnets may not produce a fully waterproof seal on the tissue. To address 
this issue, an additional screw and gasket component was added to the outside of the chamber to 
ensure a waterproof seal.   
 
2.5 Device Design and Fabrication (Prototype #1)  
Once the initial design approach was determined, Creo Parametric 2.0 was used to 
produce CAD drawings of a preliminary chamber design. Figure 2.2 shows the bottom chamber 
component which has an internal flow chamber to apply shear stress on the endothelial layer of 
an en face mouse aorta and an outside chamber in which the magnet is placed. Fluid flow enters 
from the side port and travels an L pattern to the top cut out inside the innermost chamber and 
leaves out the other end. Holes for the screw and gasket component are also at the chamber edges 
but were omitted in this image to simplify the design. Figure 2.3 shows the bottom chamber 
assembly with the magnet inserted in the outer chamber and the tissue and gasket layers on top. 
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Figure 2.4 shows the top chamber component which has only one chamber to accommodate both 
the magnet and an internal smooth muscle cell fluid chamber. The fluid enters and leaves 
through top inlet and outlet ports. Holes for the screw and gasket component again were omitted. 
Figure 2.5 is an exploded view of the entire assembly. In this image the cast acrylic chambers are 
depicted in gray, the magnets in black, the silicone gasket in red and the tissue section in pink. 
Once the CAD designs were completed, they were taken to the Drexel Machine Shop to 
produce an initial prototype. Figure 2.6 is a picture of all of the pieces of the resulting top 
chamber, screw, gasket, and bottom chamber respectively alongside a penny to provide chamber 
size perspective. Figure 2.6 also displays a top and side view of the resulting chamber fully 
assembled. This design incorporated 1/64 inch thick Flexible Magnetic Sheeting (McMaster-Carr 
5756K51) with adhesive pre-applied to the back of the magnets set in both the top and bottom of 
the chamber. This was selected because of its thin dimensions to allow for a chamber height 
within the range of imaging. Both the magnet sheeting and the silicone gasket were laser 
machined for precision to fit within the chamber design. Stainless steel ports held in place by 
Biocompatible Advanced Performance Adhesive (Adhesive Systems – MG45) were used for 
flow ports. These were selected because conventional screw in ports have an outer dimension too 
large for the chamber dimensions.  
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Figure 2.2. CAD drawing of initial bottom chamber created in Creo Parametric 2.0. 
 
 
Figure 2.3. CAD drawing of assembled bottom chamber with magnet (black), gasket (red), and 
tissue (pink). 
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Figure 2.4. CAD drawing of initial top chamber created in Creo Parametric 2.0 
 
 
Figure 2.5. An exploded view of the entire design assembly. Top and bottom chamber (grey), 
magnets (black), gasket (red), tissue (pink). 
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Figure 2.6. Completed first prototype. (a) Individual components (right-left: top chamber, 
screw, gasket, bottom chamber. (penny included for size reference)). (b) top view of assembled 
chamber. (c) side view of assembled chamber. 
 
2.6 Device Testing (Prototype #1)  
2.6.1 Material cytotoxicity 
Cytotoxicity of the magnets, stainless steel and glue were performed according to the 
American Society for Testing and Materials Standard for Cell Cytotoxicity in Direct Contact 
protocol (ASTM F813-2012). Briefly, porcine aortic endothelial cells were seeded using 1 mL of 
PAEC cell suspension at a density of 75,000 cells/mL (~20,000 cells/cm2) and allowed to reach 
confluence for 72 hours in normal culture conditions (in DMEM at 37 °C and 5 % CO2). 
Materials being tested were exposed to UV light for 15 minutes to sterilize before being added to 
culture dishes (glue was allowed to dry for 72 hours prior to adding). As a positive and negative 
control, 5% DMSO and 5% PBS were used respectively for comparison. Cultures were allowed 
to incubate from 24 hours in normal culture conditions prior to imaging. Phase contrast images 
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were then taken to confirm minimal differences between sample and negative controls. The cast 
acrylic and silicone were excluded from this testing based on the fact that they have been 
commonly used previously in many flow chamber designs (GlycoTech, 2004). The magnets used 
were 1/64 inch Flexible Magnetic Sheeting (McMaster-Carr 5756L51) with an adhesive back. 
The stainless steel was medical grade stainless steel available at the Drexel University Machine 
Shop. The glue used was Medical Grade Advanced Performance Instant Adhesive (Adhesive 
Systems MG45-UPS Class 6). As seen in Figure 2.7, the magnets, stainless steel and glue were 
determined to be non-toxic because there was no visible difference between the control and 
treated images.  
 
Figure 2.7.  Cytotoxicity Testing (ASTM F813-2012) for magnets, stainless steel and glue 
used in chamber design. There was no visible difference between the control and treated 
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images, suggesting that these materials were not cytotoxic. Red box indicates samples treated 
with materials while black indicates either positive or negative controls. 
 
2.6.2 Leak testing 
The water proof seal of the entire chamber was first evaluated by flowing colored water 
through both chambers. No visible leaks were observed. The internal seal between the top and 
bottom fluid chambers was then evaluated by flowing colored water through one chamber and 
clear water through the other chamber and evaluating the color of the fluid exiting the chamber at 
the other end. Parafilm strips were used to mimic tissue in the chamber. Figure 2.8 shows an 
image of the green colored water flowing through the top flow chamber path but not 
contaminating the clear water flowing through the bottom chamber path.  Since cross 
contamination was not observed, it was determined that there was an adequate seal.  
 
Figure 2.8.  Leak testing was performed using colored and non-colored water to confirm 
that the chamber sealed properly. Green dye can be seen in tissue chamber but was not 
detected in bottom flow path containing clear water. 
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2.6.3 Limitations of prototype #1 
Initial testing of this first prototype revealed three main design flaws. The first was the 
overall size of the device which was too small for practical assembly and use. Assembling the 
chamber for initial testing became time consuming and difficult with all of the small pieces and 
the number of screws. In addition, the outer flow chamber dimensions were not ideal for imaging 
since they were too small to fit on a standard microscope stage. For the second prototype, this 
was addressed by making the overall outside dimensions of the chamber much larger and 
reducing the number of screws in the design.  
The second design flaw was the inability of the magnets to hold the tissue in place. This 
was seen by the chambers inability to accommodate alternate tissue structures such as porcine 
valve tissue without the obstruction of the flow path and a reduction of the water tight seal 
previously seen with parafilm. The tissue was also not easily secured in the chamber before the 
gasket was sealed. This was addressed by purchasing larger and stronger magnets which would 
be independent from the top chamber. The larger magnets provide greater strength to seal the 
tissue in place before the top chamber is assembled. Because the magnet is independent of the 
top chamber, tissue placement can be adjusted before the entire chamber is sealed. This provides 
a more stable chamber with more definitive tissue placement.  
The third design flaw was the inability of the glue to secure the top flow ports in place. 
After three to four weeks of testing, there was a direct incision of one stainless steel port through 
the top and into the bottom chamber. For a second prototype, this was addressed by making two 
different size holes in the top chamber, one which accommodated the stainless steel port 
dimensions and a second which is smaller to allow for fluid flow but not the port intrusion into 
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the chamber body. With this adjustment the glue used in the first prototype was eliminated 
removing any cytotoxicity concerns from the second design 
  
2.7 Device Design and Fabrication (Prototype #2)  
Creo Parametric 2.0 was used to produce a second set of CAD drawings for the updated 
prototype. Figure 2.9 shows the updated assembled bottom chamber component which is similar 
to the previous one described but incorporates 1/32 inch Flexible Magnetic Sheeting (McMaster-
Carr 5756K55). In this image the cast acrylic is depicted in gray, the silicone gasket in red and 
the flexible magnet in blue. Figure 2.10 shows the updated top component of the chamber which 
now has two chambers to accommodate the larger and more powerful Rare Earth Neodymium 
Magnets (1/2” x 1/8” x 1/16”).  
Once the CAD designs were completed, they were taken to the Drexel Machine Shop to 
produce a second prototype. Figure 2.11a is a picture of all of the pieces of the resulting top 
chamber, screw, gasket, and bottom chamber respectively alongside a penny to provide 
perspective to the larger chamber size. Figure 2.11 also displays a top (Figure 2.11b), bottom 
(Figure 2.11c) and side view (Figure 2.11d) of the resulting chamber fully assembled. This 
design incorporated 1/32 inch thick Flexible Magnetic Sheeting (McMaster-Carr 5756K51) with 
adhesive pre-applied to the back of the magnets set in the bottom chamber only. This magnet 
was selected because of its thin dimensions to still allow for a chamber height within the range of 
imaging. Both the flexible magnetic sheeting and the silicone gasket were laser machined for 
precision to fit within the chamber design. This design also incorporated rare Earth Neodymium 
Magnets because it allowed for much better magnetic strength but still maintained dimensions 
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small enough to fit in the chamber. These magnets were not adhered within the chamber to allow 
for easier adjustment and assembly. Stainless steel ports were held in place by laser machining 
the cast acrylic which eliminated the need for any adhesive.  
 
 
Figure 2.9. A CAD design of the new assembled bottom chamber (grey) with magnet (blue) and 
gasket (red). 
 
 
Figure 2.10. A CAD drawing of the new top chamber modified to accommodate the stronger 
Neodymium magnets. 
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Figure 2.11. Completed second prototype. (a) Individual components (right-left: top chamber, 
screw, gasket, bottom chamber. (penny included for size reference)). (b) top view of assembled 
chamber. (c) bottom view of assembled chamber. (d) side view of assembled chamber. 
 
2.8 Device Testing (Prototype #2)  
2.8.1 Material cytotoxicity 
Cytotoxicity of the new Rare Earth Neodymium Magnets were assessed according to the 
American Society for Testing and Materials Standard for Cell Cytotoxicity in Direct Contact 
protocol (ASTM F813-2012) to reconfirm the chamber biocompatibility. As seen in Figure 2.12, 
a 
d 
c b
h 
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the magnets appears to have some effect on the cells; however, there is no indication of cell 
death. In addition, the magnets never come into direct contact with the cells being tested or the 
fluid flow path and therefore the cytotoxicity of the magnets are not as important. As a positive 
and negative control, 5% DMSO and 5% PBS were used respectively for comparison. 
 
 
Figure 2.12. Cytotoxicity Testing (ASTM F813-2012) for new Neodymium magnets used in 
second prototype. There was some effect of the magnet on the cells however there is no 
indication of cell death. Red box indicates samples treated with materials while black indicates 
either positive or negative controls. 
 
2.8.2 Leak testing 
The water proof seal of the entire chamber was first evaluated by flowing colored water 
through both chambers and observing any leaks. From this testing, because of the increased size 
of the chamber, leakage into the gasket was observed (Figure 13a). To resolve this issue, 10 
additional screws were added around the center of the chamber to prevent leakage (Figure 13b).  
 
32 
 
 
Figure 2.13. Additional screws added to chamber to maintain seal around tissue 
compartment. (a) A lack of a tight seal around the internal compartment of the chamber was 
addressed by adding 10 additional screws around the center (b).  
 
Once the additional screws were added, the internal seal between the top and bottom fluid 
chambers was then evaluated. This was done by flowing colored water through one chamber and 
clear water through the other chamber and evaluating the color of the fluid exiting the chamber at 
the other end. Strips of parafilm were used to mimic tissue in the chamber. Figure 14 shows an 
image of the green colored water flowing through the top flow path of the chamber and clear 
water flowing through the bottom flow path. As a result of this experiment, it was determined 
that there was an adequate seal because cross contamination of green dye into the clear fluid path 
was not observed. 
 
Figure 2.14.  Leak testing was performed using colored and non-colored water to confirm 
that the chamber sealed properly. Green dye can be seen in the tissue chamber but was not 
detected in bottom flow path containing clear water. 
a b 
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 Initial testing of the chamber for its ability to be used with fluorescent imaging and cell 
viability was conducted by labeling the thoracic aorta of a mouse. Using a Live-Dead Assay 
protocol, 2 mM EthD-1 and 1 mg/mL of Calcain AM were used to stain the cells of the tissue 
along with 5 µg/ml Hoechst used to label the cell nuclei. The vessel was then sealed into the 
chamber with tissue specific HEPES buffer filling the channels of the device but no flow was 
administered. The vessel was then imaged using both 10x and 20x magnification on the Olympus 
Fluoview 1000 Confocal Microscope. A representative images of the endothelial and smooth 
muscle cell layers of the tissue can be seen in Figure 2.15. The alignment of the nuclei (red 
arrow) was used to determine the cell layer. The presence of green fluorescence but absence of 
red fluorescence detected in these images indicates that the tissue was kept alive.  
 
 
Figure 2.15. Fluorescent images of EC and SMC layer of a mouse thoracic aorta in tissue 
chamber. Red arrow indicates direction of cell alignment used to determine cell layer. Blue is 
nuclei labeling. Green indicates live cell staining. Red indicates dead staining. 
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2.9 Design Limitations 
 The shear stress parameters of the device were calculated modeling the flow chamber as 
an infinite parallel plate. These calculations do not take into account the effect of the chamber 
walls on flow assuming that the width is much larger than the height of the chamber. However, 
because the chamber width was restricted by the size of the explanted vessel and is only double 
the height of the flow path, this assumption is not fully valid. The effects of flow at the edges of 
the chamber may affect the results of any assay using this chamber. 
 In addition, while the stronger Neodymium magnets were independent of the cast acrylic 
flow chamber, they were more attracted to each other than the magnetic sheets. To overcome 
this, assembly must be done inversely. The Neodymium magnets must be locked in place within 
the top chamber before the tissue is oriented in place and the bottom chamber is placed on top 
and sealed. Additionally, the laser cut magnetic sheets contained an adhesive back sealing them 
into the chamber. Once the adhesive wore away the magnetic sheets were used independently 
from the bottom chamber to adjust the tissue prior to sealing the chamber. One improvement 
over the current design would be to purchase magnetic sheets that did not have an adhesive back 
to allow for better adjustment of the tissue.  
 Additionally, the security of the vessel within the chamber and the ability for the magnets 
to ensure a flat vessel for imaging is questionable. The assembly of the device is difficult 
primarily due to very small size of the tissue. While the magnets are able to adhere the tissue in 
place, slight adjustments to the magnets position during the full chamber assembly can cause 
wrinkles in the vessel. The inability for the chamber to maintain pressure within the vessel is also 
a concern.  
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2.10 Achievement of Design Objectives 
 To obtain a shear stress of 20 dynes/cm2 with the designed device a flow rate of 
approximately 6.4 mL/min would need to be used determined from Equation 1 previously stated. 
With this flow rate the Reynolds number of the flow system was determined to be approximately 
135 which is below the 2000 threshold for laminar flow. The internal flow chamber design (8 
mm x 1 mm) was determined to be small enough to adequately incorporate the thoracic aorta of a 
mouse. A waterproof seal was established with the gasket and additional set of screws around the 
tissue chamber and the flow paths were shown to be separate. Fluorescent images of the vessel 
were successfully obtained within the chamber showing its compatibility with fluorescent 
microscopy. Further testing must be done to confirm vessel fixation and cell viability under flow 
conditions, however; the chamber’s performance appears to be promising.  
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3. ENDOTHELIAL CELL IN VITRO PERMEABILITY 
3.1 Introduction 
Endothelial cells form a selective semi-permeable barrier to regulate movement of solutes 
into the arterial wall, which contributes to cholesterol accumulation and atherosclerotic plaque 
development (Alberts et al., 2002). A direct correlation between hypertension severity and 
endothelial impairment has previously been shown (Dharmashankar & Widlansky, 2010). 
Hypertension has been established as a risk factor for atherosclerosis; however, the mechanism 
by which hypertension contributes to the disease remains unclear (Lithell, 1994). 
Hypertension increases vessel stiffness. Coutinho et al. have shown that arterial stiffness 
is directly correlated to an increase in mean, systolic and pulse pressure in treated hypertensive 
patients over a mean period of 8.5 years (Coutinho et al., 2014). Changes in substrate stiffness 
can alter cell-cell interactions which are directly linked to monolayer integrity and permeability 
(Reinhart-King et al., 2008). Paracellular endothelial permeability is controlled in part by the 
endothelial cell-cell junctions which are affected by interactions between endothelial cell and 
substrates (Dejana et al., 2008). Substrate stiffening has also been shown to increase endothelial 
monolayer permeability as a result of increased cell contractility through mechanical disruption 
of cell-cell junctions (Huynh et al., 2011).   
Hypertension and many cardiovascular diseases are associated with increased 
inflammation.  A relationship between blood pressure measurements and inflammatory marker 
(sICAM-1 and IL-6) levels was established in healthy men (Chae et al., 2001). Additionally, pre-
hypertensive patients showed a 32% increase in the inflammatory cytokine tumor necrosis factor 
alpha (TNF-α) compared to normotensive patients (Chrysohoou et al., 2004). Inflammatory 
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cytokines such as TNF-α disrupt vascular integrity (Zhang et al., 2009). TNF-α has also be 
shown to cause actin stress fiber formation and cell contraction through the Rho/ROCK pathway 
which increases monolayer permeability through the loss of cell-cell junctions in human 
umbilical vein endothelial cells on glass coverslips (Wojciak-Stothard et al., 1998). This can 
facilitate the buildup of plaque by increasing the expression of endothelial cell adhesion 
molecules, increasing endothelial cell leakiness and inducing smooth muscle cell proliferation 
(Wojciak-Stothard et al., 1998). 
While both TNF-α and substrate stiffness increase endothelial permeability, the effect of 
substrate stiffness on TNF-α induced endothelial monolayer disruption has not been investigated. 
This chapter describes the development of an in vitro permeability assay for endothelial cell 
monolayers on substrates of different stiffness exposed to the inflammatory cytokine tumor 
necrosis factor-α (TNF-α). Endothelial monolayer permeability was then assessed on 
polyacrylamide gels of three different stiffnesses when cells were treated with both TNF-α and 
thrombin. 
 
3.2 Methods and Materials 
3.2.1 Cell Culture 
 Porcine aortic endothelial cells (PAEC) were used for all in vitro experiments. The cells 
were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% penicillin, 
streptomycin, and glutamine and 5% fetal bovine serum (FBS) at 37 °C and 5% CO2. The cells 
were maintained from passages 5 to 9 for experiments and were provided new media every 2 
days. Cells were passaged when they reached confluence using 0.025% Trypsin-EDTA. 
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3.2.2 Polyacrylamide Gels 
Polyacrylamide (PA) gels were used to create substrates of varied stiffness. The process 
used to produce the PA gel cell substrates is illustrated in Figure 3.1.  12 mm circular top glass 
coverslips were made by applying a thin layer of Surfasil siliconizing fluid to the coverslip 
surface for approximately 30 seconds. The Surfasil was removed by wiping the coverslip with a 
Kimwipe, and the coverslips were heated at 75°C for 15 minutes.  This treatment rendered the 
top coverslips hydrophobic, which enabled their removal from the gel surface following gel 
polymerization.  The hydrophobic top coverslip is depicted with a red dashed line in Figure 3.1a. 
Hydrophilic 22 mm square bottom glass coverslips were made for the gels to adhere to by 
incubating the coverslip with 0.1 M sodium hydroxide (NaOH) for 3 minutes. The NaOH was 
then completely removed and replaced with (3-aminopropyl)trimethoxysilane (3-APTMS) for 
another 3 minutes. The 3-APTMS was also completely removed and the coverslips were washed 
thoroughly with deionized water for 30 minutes. Following the wash, the coverslips were dried 
and treated with 0.5% glutaraldehyde for 30 minutes before removing the glutaraldehyde and 
storing coverslips in a vacuum chamber.  The hydrophilic bottom coverslip is depicted with a 
green dashed line in Figure 3.1.a.       
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Figure 3.1.  PA gels were used to vary substrate stiffness in vitro. (a) Coverslips were 
chemically treated to be hydrophilic (green) or hydrophobic (red). (b) The top coverslip was 
inverted over polymerizing gel on the bottom coverslip. (c) Gels were incubated to finalize 
polymerization. (d) Gels were functionalized with collagen using sulfo-SANPAH. Cells were 
seeded on the gels. 
 
A gel solution was then created by combining a varying percentage of acrylamide and 
bis-acrylamide (Table 3.1) to create gels of differing stiffness. 0.3% N,N,N´,N´-
tetramethylethylenediamine (TEMED) and 1% ammonium persulfate (APS) were used to 
crosslink the acrylamide and bis-acrylamide. Later experiments incorporated 10 µM of 40 kDa 
fluorescein labeled Dextran (FITC Dextran) to the gel solution prior to crosslinking. The solution 
was then quickly pipetted onto the bottom coverslip and a top coverslip was inverted on the gel 
layer to form a flat surface and an evenly distributed gel (Figure 3.1b). The gel was polymerized 
for approximately 2-3 minutes with the top coverslip in place (Figure 3.1c).  After the gel had 
polymerized, the top coverslip was removed and gels were stored at 4 °C in 50 mL 4-(2-
Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) buffer at a pH of 8.5. The HEPES 
buffer was removed and a 0.45 µg/mL sulosuccinimidyl 6-(4’-azido-2’ –
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nitrophenylamino)hexanoate (sulfo-SANPAH) solution was added to the top of the gel and 
placed under ultraviolet light for 10 minutes (represented by the orange gel in Figure 3.1d). The 
sulfo-SANPAH solution was removed and the gels were washed again with the HEPES buffer. 
The HEPES was removed and the gels were inverted over a 100 μg/mL collagen type I solution 
diluted in phosphate buffered saline (PBS) overnight. Gels were rinsed and stored in PBS at 4 °C 
in tissue culture treated 6-well plates.  Gels were exposed to UV light for 15-60 minutes prior to 
cell seeding to ensure substrate sterility.  
 
Table 3.1.  Acrylamide and Bis-acrylamide concentrations for polyacrylamide gels of 
varying stiffness. Different percentages of acrylamide, bis-acrylamide and water were used to 
create three different stiffness gel solutions used for the in vitro assay. 
 
 
3.2.3 Cell Seeding 
Porcine aortic endothelial cells (PAEC) were seeded onto the gel at a density of 75,000 
cells/mL (~15,800 cells/cm2) and incubated in DMEM at 37 °C and 5 % CO2 for 3 days to 
achieve a confluent cell layer (Figure 3.2). After the third day, the 5% FBS DMEM was replaced 
with 1% FBS DMEM containing the same 1% penicillin, streptomycin, and glutamine and 
allowed to incubate overnight before any treatments were administered.  
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Figure 3.2. Endothelial cell monolayer on a polyacrylamide gel. Phase contrast image shows 
a fully confluent endothelial cell monolayer on a 6 kPa polyacrylamide gel.  
 
Thrombin, a barrier disruptive molecule used as a positive control, was administered at a 
concentration of 10 units/mL for 30 minutes (Huynh et al., 2011). BW245, a barrier enhancing 
molecule used as a negative control, was administered at a concentration of 1 µM for 30 minutes 
(Huynh et al., 2011). Samples were treated with 10 ng/mL TNF-α for three hours for all 
experiments. This concentration was chosen based on previous literature and our own 
experiments which show it to be high enough to cause a response to but low enough to not 
induce apoptosis (Zhang et al., 2009). In addition, preliminary data showed the largest change in 
cell stiffness at this timepoint.    
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3.2.4 Permeability Assay 
Tetramethylrhodamine fluorescently labeled dextran (rhodamine dextran) diffusion 
through a confluent endothelial monolayer into the gel substrate was used to quantify endothelial 
cell permeability. A schematic assay representation is shown in Figure 3.3. The method was 
adapted from an existing protocol (Huynh et al., 2011).  Samples were treated with 10 µM 
rhodamine dextran (40 kDa or 10 kDa) suspended in CO2 independent media for 5 minutes. In 
initial experiments, Differential Interference Contrast (DIC) microscopy was used to determine 
the border between the gel and the cell layer.  DIC was later replaced with fluorescein-labeled 
(FITC) dextran in the gel, which provided a fluorescent demarcation of the gel surface (described 
in detail in Figure 3.4). The samples were then imaged by confocal microscopy, taking a z stack 
with images every 1 µm through the gel substrate, cell monolayer, and fluorescent dextran layer 
using an Olympus Fluoview 1000 Confocal Microscope. The rhodamine dextran was imaged 
using a 543 nm laser, and the FITC Dextran was imaged using a 488 nm laser. Approximately 
60-80 z-stack images were obtained for quantification.  
 
 
Figure 3.3.  Endothelial cell monolayer permeability was assessed using an in vitro assay. 
(a) An intact cell layer only allows a small amount of dextran to permeate into the gel layer. (b) 
A disrupted cell layer allows a larger amount of dextran to permeate into the gel layer. 
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Each z-stack was quantified using ImageJ. First the images were cropped to a 199.96 by 
199.96 pixel size. Limiting image size minimized the contribution of any gel surface unevenness. 
The fluorescent channels were then converted from the xy plane to the xz plane using the reslice 
function, providing a view of the fluorescence in the gel and liquid layers. The average pixel 
intensity of a set 20 µm depth within the gel directly below the cell layer was measured (Figure 
3.4a). The cell layer location was determined by FITC dextran location (Figure 3.4b). The 
fluorescence intensity within the gel was normalized to the fluorescence intensity of the liquid 
layer to account for any differences in brightness among samples. In addition, gels containing no 
cell layer were used to normalize results among experiments. 
 
 
Figure 3.4. Rhodamine dextran was quantified in the first 20 µm of the PA gel, as 
determined by the FITC dextran incorporated in the gel. Dotted line indicated the top of the 
gel, yellow box indicated the first 20 µm of the gel used to quantify Rhodamine intensity within 
the gel. 
 
3.2.5 Statistical Analysis 
Statistical analysis was performed using Microsoft Excel and MATLAB. Data are 
presented graphically as mean ± standard deviation. Comparisons between treated and control 
conditions were analyzed using Student’s t-tests in Excel. Comparisons among more than two 
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groups were performed in MATLAB using a one-way ANOVA, and a Tukey-Kramer post hoc 
test was performed to analyze significance between each condition. MATLAB was also used to 
perform a two-way ANOVA with varying sample size (n) on the interaction between substrate 
stiffness and treatment type. A p-value of less than 0.05 was considered statistically significant 
(**) p < 0.001, (*) p < 0.01, (#) p < 0.05.  
 
 
3.3 Results 
3.3.1 Assay Development 
 Originally, samples were imaged by inverting the gel onto the rhodamine dextran 
solution so the cell layer was facing down toward the microscope. Using a 60x oil immersion 
lens, the PA gel, cell, and liquid layers were clearly visible (Figure 3.5).  
 
 
Figure 3.5. Inverted imaging procedure using 60x oil immersion lens clearly shows the PA 
gel, cell and liquid layers. The white box indicates the area quantified for gel intensity and the 
black box indicates the area quantified for liquid intensity. 
 
However, variability associated with this method was high, likely because the volume of 
rhodamine dextran which remained trapped under the PA gel varied and the gels tended to sink 
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into the liquid layer. This made measuring the liquid layer difficult, which led to inconsistent 
quantification. Figure 3.6 shows the liquid layer and gel intensity variability in untreated samples 
imaged with the inverted protocol. 
 
Figure 3.6. The inverted gel method led to high variability in rhodamine dextran liquid 
intensity. The liquid volume trapped under the inverted gels was inconsistent, affecting the gel 
intensity in untreated samples. Each sample contained a confluent monolayer of PAECs on a 6 
kPa PA gel. Samples were incubated with 10 µM 40 kDa rhodamine dextran for 5 minutes prior 
to confocal imaging with 60x oil immersion lens. Each image was converted from xy to xz plane 
and compressed based on average pixel intensity.  
 
The inverted imaging protocol was originally selected to avoid imaging through the gel. 
The original gels were approximately 450 µm thick, as determined from the gel solution volume 
and 12 mm circular coverslip surface area. These gels were thicker than the microscope range 
and therefore the cell and liquid layer could not be imaged if they were on top of the gel. In 
addition, imaging through a thick gel could decrease image quality.   
An upright protocol was developed by making thinner gels using a smaller gel solution 
volume. The working distance for the 60x confocal microscope objective was approximately 200 
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µm, which would have required extremely thin gels. However, the working distance for the 20x 
objective was approximately 600 µm. By reducing the gel height to approximately 170 µm, we 
could image all the way through the gel, cells, and into the rhodamine dextran liquid layer 
(Figure 3.7).  
 
 
Figure 3.7. Calculations used to determine gel height for upright imaging with 20x lens. 
Blue represents the coverslip, green represents the gel, and red represents the cell and liquid 
layer. 
  
To determine the appropriate rhodamine dextran concentration, a range of concentrations 
between 0.5 and 50 µM were assessed. Figure 3.8 shows 5 compressed z-stack images within the 
liquid layer, indicating average pixel intensity for each condition. From these images, we 
determined that 0.5 µM did not produce enough fluorescence intensity to ensure that we could 
measure dextran permeation into the gel. 50 µM produced a saturated liquid layer intensity, 
which was determined to be too high. 5 µM appeared to have enough fluorescence intensity to 
adequately capture fluorescence without oversaturating the image. However, to ensure the 
intensity was easily detected, 10 µM rhodamine dextran was used, which was also consistent 
with concentrations in the literature (Huynh et al., 2011).  
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Figure 3.8. Concentration gradient of rhodamine dextran used for the liquid layer. 10 µM 
Dextran was the final concentration selected because of the desire to increase the intensity from 
the 5 µM Dextran condition but not saturate the images as the 50 µM Dextran shows. Each 
sample contained a confluent monolayer of PAECs on a 6 kPa PA gel. Samples were incubated 
with 40 kDa rhodamine dextran for 5 minutes prior to confocal imaging with 20x lens. Top 5 z-
stacks within the liquid layer were compressed based on average pixel intensity. 
 
3.3.2 Assay Validation 
 The in vitro permeability assay was validated with thrombin as a positive control. 
Thrombin has previously been shown to increase endothelial cell monolayer permeability by 
causing cells to pull apart. Two concentrations of thrombin were tested based on the literature: 4 
and 10 units/mL. All samples were treated with thrombin for 30 minutes prior to imaging. Four 
images were obtained for each condition (Figure 3.9). Gel fluorescent intensity increased 30%  
(p < 0.01) when cells were treated with 10 unit/mL thrombin as compared to control, indicating 
increased endothelial monolayer permeability (Figure 3.10).  
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Figure 3.9. Images obtained for samples treated with varying thrombin concentrations 
showing an increase in fluorescence within the gel for samples treated with 10 unit/mL 
thrombin. Each sample contained a confluent monolayer of PAECs on a 6 kPa PA gel. Samples 
were incubated with 10 µM 40 kDa rhodamine dextran for 5 minutes prior to confocal imaging 
with 20x lens. Each image was converted from xy to xz plane and compressed based on average 
pixel intensity.  
 
 
Figure 3.10.  Gel fluorescent intensity increased on 6 kPa gels when samples were treated 
with 10 units/mL thrombin. Intensity was normalized to liquid layer. n = 4. * p < 0.01 
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BW245C was selected as a positive control because it has previously been shown to 
increase the integrity of endothelial cell monolayers by inhibiting ROCK. Two BW245C 
concentrations were selected based on literature: 0.3 µM and 1 µM (Kobayashi et al., 2013; 
Murata et al., 2008). All samples were treated with BW245C for 30 minutes prior to imaging. 
Three images were obtained for each condition (Figure 3.11). Gel fluorescent intensity decreased 
30% (p < 0.05) when cells were treated with 1 µM BW245C as compared to control, indicating 
decreased endothelial monolayer permeability (Figure 3.12). 
 
 
Figure 3.11. Images obtained for samples treated with varying BW245C concentrations 
showing a decrease in fluorescence within the gel for samples treated with 1 µM BW245C. 
Each sample contained a confluent monolayer of PAECs on a 6 kPa PA gel. Samples were 
incubated with 10 µM 40 kDa rhodamine dextran for 5 minutes prior to confocal imaging with 
20x lens. Each image was converted from xy to xz plane and compressed based on average pixel 
intensity. 
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Figure 3.12.  Gel fluorescent intensity decreased on 6 kPa gels when samples were treated 
with 1 µM BW245C. Intensity was normalized to liquid layer. n = 3. # p < 0.05. 
 
 Cell monolayer permeability following treatment with the controls was repeated to 
confirm the assay. 1 µM BW245C and 10 unit/mL Thrombin were used. All samples were 
treated for 30 minutes prior to imaging. Four images were obtained for each condition (Figure 
3.13). DIC images of the monolayer were also obtained to confirm that the monolayer integrity 
was maintained (Figure 3.14). From the quantification of these images, gel fluorescent intensity 
decreased 16% (p < 0.05) in cells treated with 1 µM BW245C. Gel fluorescent intensity 
increased 28% (p < 0.5) in cells treated with 10 unit/mL thrombin (Figure 3.15).  
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Figure 3.13. Images obtained for samples treated with 10 units/mL thrombin and 1µM 
BW245C showing an increase in fluorescence within the gel for samples treated with 10 
units/mL thrombin and a decrease in fluorescence within the gel for samples treated with 1 
µM BW245C. Each sample contained a confluent monolayer of PAECs on a 6 kPa PA gel. 
Samples were incubated with 10 µM 40 kDa rhodamine dextran for 5 minutes prior to confocal 
imaging with 20x lens. Each image was converted from xy to xz plane and compressed based on 
average pixel intensity. 
 
 
Figure 3.14.  Dextran diffusion into the gel was observed through z-stack cross-sections and 
correlated with endothelial monolayer integrity. Increased gel fluorescence (top, confocal z-
stack) indicates increased cell permeability due to monolayer disruption (bottom, DIC). 
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Figure 3.15.  Gel fluorescent intensity increased in cells treated with 10 units/mL Thrombin 
and decreased in cells treated with 1 µM BW245C on 6 kPa PA gels. Intensity was 
normalized to liquid layer and samples without cells. n = 4. # p < 0.05. 
 
Establishment of both a positive and negative control provided the confidence to use this 
assay to analyze the effect of TNF-α. 
 
3.3.3 TNF-α-induced Monolayer Permeability on Substrates of Varying Stiffness: 40 kDa dextran   
 TNF-α induced endothelial cell monolayer permeability was then evaluated on all three 
stiffness gels. Treated samples were incubated with 10 ng/mL TNF-α for three hours prior to 
imaging. Five to six samples were imaged for each condition and each experiment was repeated 
to confirm that the results are consistent (Figure 3.16). Gel fluorescent intensity increased 34%, 
23% and 35% (p < 0.5) in cells treated with TNF-α on 6kPa, 14kPa and 29kPa gels, respectively 
(Figure 3.17). In addition, a two-way ANOVA indicated a significant difference among 
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stiffnesses (p = 0.01); however, the interaction between stiffness and treatment was not 
statistically significant (p = 0.94). This may be due to the variability in the experiments. 
 
6 kPa 
 
 
 
 
 
 
 
 
 
14 kPa 
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29 kPa 
 
 
 
 
 
 
 
 
 
Figure 3.16. Data obtained for samples treated with 10 ng/mL TNF-α on PA gels of varying 
stiffness showing an increase in fluorescence within the gel for samples treated with 10 
ng/mL TNF-α however no interaction between treatment and stiffness was observed. Each 
sample contained a confluent monolayer of PAECs on a 6, 14 or 29 kPa PA gel. Samples were 
incubated with 10 µM 40 kDa rhodamine dextran for 5 minutes prior to confocal imaging with 
20x lens. Each image was converted from xy to xz plane and compressed based on average pixel 
intensity. Intensity was normalized to liquid layer and samples without cells. n = 6 (6 kPa data); 
n = 5 (14 and 29 kPa data). # p < 0.05. * p < 0.01. 
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Figure 3.17. Endothelial monolayer permeability increased with TNF-α on 6, 14, and 29 
kPa PA gels. However, stiffness did not have an effect. Intensity was normalized to liquid 
layer and samples without cells. n = 6 (6 kPa data). n = 5 (14 and 29 kPa data). # p < 0.05. * p < 
0.01. 
 
 Although a trend of increased permeability with stiffness appears from the data, the 
difference was not statistically significant. This may be a result of the assays high variability and 
low sensitivity. We therefore worked to optimize the parameters of this assay to improve 
sensitivity and decrease variability.  
 
3.3.4 Increasing Sensitivity of Permeability Assay 
 Reevaluating the data from previous experiments, it was noted that 40 kDa rhodamine 
dextran diffusion into the gels decreased as gel stiffness increased. Even the samples with no cell 
layer presented this trend (Figure 3.18). If dextran cannot diffuse into the gel, then we could not 
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observe any endothelial permeability changes. We therefore tried different methods to increase 
dextran diffusion into the gel. 
 
Figure 3.18. Decreased rhodamine dextran in the stiffer gels with no cell layers. Each gel 
was incubated with 10 µM 40 kDa rhodamine dextran for 5 minutes prior to confocal imaging 
with 20x lens. Each image was converted from xy to xz plane and compressed based on average 
pixel intensity.  
 
 Dextran incubation time was first increased to determine if that could increase 40 kDa 
rhodamine dextran diffusion into the stiffer gels. An increased time of 15 minutes was compared 
to the 5 minutes previously used. Figure 3.19 shows a z-stack of the two images taken for each 
condition on all three stiffness gels. There was no statistically significant increase in permeability 
with the samples treated with 40 kDa rhodamine dextran for 15 minutes when compared to the 
samples treated for 5 minutes (Figure 3.20). In addition, the longer time point caused the 
difference between the average permeability of the 6 kPa gels and the 29 kPa gels to increase 
from 46% to 56%. 
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Figure 3.19. Images obtained for samples with increased rhodamine dextran incubation 
time showing no improvement for fluorescence intensity measurement difference between 
different stiffness gels. Each sample was incubated with 10 µM 40 kDa rhodamine dextran prior 
to confocal imaging with 20x lens. Each image was converted from xy to xz plane and 
compressed based on average pixel intensity.  
 
 
Figure 3.20. Increasing the Rhodamine incubation time increased the difference in 
permeability measured between the 6 kPa and 29 kPa gels with no cell layer. Intensity was 
normalized to liquid layer. n = 2. 
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Dextran concentration was the next parameter evaluated to determine having more 40 
kDa rhodamine dextran would improve diffusion into the stiffer gels. An increased concentration 
of 25 µM was incubated on gels without cell monolayers, compared to the 10 µM concentration 
previously used. Figure 3.21 shows a z-stack of the two images taken for each condition on all 
three stiffness gels. There was no statistically significant increase in gel fluorescence intensity 
with the samples treated with 25 µM 40 kDa rhodamine dextran compared to the samples treated 
with 10 µM (Figure 3.22). The increased dextran concentration did cause the difference between 
the average fluorescence of the 6 kPa gels and the 29 kPa gels to decrease, but only slightly from 
52% to 49%. 
 
 
Figure 3.21. Images obtained for samples treated with increased concentration of 
rhodamine dextran showing no improvement for fluorescence intensity measurement 
difference between different stiffness gels. Each sample was incubated with 40 kDa rhodamine 
dextran for 5 minutes prior to confocal imaging with 20x lens. Each image was converted from 
xy to xz plane and compressed based on average pixel intensity. 
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Figure 3.22. Increasing the rhodamine dextran concentration slightly increased the 
difference in permeability measured between the 6 kPa and 29 kPa gels with no cell layer. 
Intensity was normalized to liquid layer. n = 2. 
 
Dextran size was the final parameter evaluated to determine if the 40 kDa Rhodamine 
Dextran was too large to allow for adequate diffusion into the stiffer 29 kPa gels. A decreased 
size of 10 kDa was compared to the 40 kDa size previously used. Figure 3.23 shows a z-stack of 
the two images taken for each condition on all three stiffness gels. There was a statistically 
significant increase in permeability (p < 0.01) with the samples incubated with 10 kDa 
rhodamine dextran compared to the 40 kDa rhodamine dextran on the 29 kPa gels only (Figure 
3.24). In addition, the decreased dextran size decreased the difference between the average gel 
fluorescence intensity of the 6 kPa gels and the 29 kPa gels from 52% to 28%. 
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Figure 3.23. Images obtained for samples treated with decreased rhodamine dextran size 
showing no improvement for fluorescence intensity measurement difference between 
different stiffness gels. Each sample was incubated with 10 µM rhodamine dextran for 5 
minutes prior to confocal imaging with 20x lens. Each image was converted from xy to xz plane 
and compressed based on average pixel intensity. 
 
 
Figure 3.24. Decreasing the rhodamine dextran size reduced the difference in permeability 
measured between the 6 kPa and 29 kPa gels. Intensity was normalized to liquid layer and 
samples without cells. n = 2.* p < 0.01. 
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 Even though dextran size did significantly decrease the variability in permeability among 
samples, it was additionally noted that the gel thickness appeared to have an effect on fluorescent 
intensity measurements within the gel. To standardize gel height to 50 µm, varying 
concentrations (1% to 0.25%) of 50 µm polystyrene beads were incorporated into the gel 
solution prior to crosslinking (Figure 3.25a). The beads should become sandwiched between the 
top and bottom coverslips and prevent the gel height from falling lower than 50 µm. 10 µM 40 
kDa FITC dextran was also added at this step to allow for imaging of the gels containing the 
beads. A weight was placed on to the top coverslip to cause it to settle onto the beads while 
crosslinking. The gel solution volume used for these samples was decreased from 20 µL to 5 µL 
to avoid excess gel during crosslinking. Z-stack images of the gels were then obtained to 
determine the gel height and bead performance. From these images, it was determined that the 
beads were contained within the gel rather than dictating the gel height. It was also noted that the 
beads fluoresced during imaging which could potentially alter intensity quantifications during 
the assay (Figure 3.25b).  Based on these observations, the use of polystyrene beads to 
standardize gel height was abandoned.  
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Figure 3.25. Polystyrene beads incorporated into the gel solution to create uniform height 
PA gels. Images still show inconsistent gel heights and beads fluoresce (red) which can alter 
intensity quantifications. FITC dextran within the PA gel was used to image gels containing 
beads. Top view (a) was used to determine the spacing of the beads within the gel suspension for 
different bead concentrations. These images were then converted from converted from xy to xz 
plane to produce a side view (b) of the beads within the gel. 
 
Even without using beads in the gel solution, decreasing the gel volume appeared to 
produce more uniformly thick gels between 30-60 µm thick.  Normalization to the fluorescence 
intensity was assessed to attempt to reduce any variability from gel thickness. PA gels of all three 
stiffnesses were created with 10 µM 40 kDa FITC dextran as previously described. Samples 
were placed under a UV lamp for one hour to simulate UV exposure during sterilization seeding 
conditions. These samples (containing no cell layer) were then incubated with 10 µM 10 kDa 
rhodamine dextran for 5 minutes (Figure 3.26). Sequential imaging was used to avoid fluorescent 
63 
 
bleed-through of the two labeled dextrans. FITC and rhodamine fluorescent intensity was 
measured in each z-stack slice (Figure 3.27a, Figure 3.27b). The FITC data were normalized to 
maximum intensity and then the rhodamine data were normalized to the FITC value to obtain a 
relative intensity within the gel layer (Figure 3.27c). Finally rhodamine fluorescence intensity in 
the first 20 µm of the gel layer, as determined by the FITC channel, was quantified (Figure 
3.27d).   
 
 
Figure 3.26. Images obtained for PA gels with no cell layers containing 40 kDa FITC 
dextran and treated with 10 kDa rhodamine dextran. FITC dextran was used to normalize the 
rhodamine dextran to account for variation in fluorescence intensity with location within the gel. 
Each sample was incubated with 10 µM 10 kDa rhodamine dextran for 5 minutes prior to 
confocal imaging with 20x lens. Each image was converted from xy to xz plane and compressed 
based on average pixel intensity. 
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Figure 3.27. Fluorescence intensity measurements of both FITC and rhodamine dextran 
used to normalize sample fluorescence to gel height. A fluorescence intensity measurement 
was obtained for each z-stack image for both FITC (a) and rhodamine (b). FITC data was 
normalized to maximum intensity and then used to normalize rhodamine data within the gel (c). 
20 µm from the top of the gel was then isolated to quantify the average intensity within the gel 
(d). 
 
FITC dextran was then used to normalize rhodamine fluorescent intensity in gels with 
and without an endothelial monolayer (Figure 3.28). The data produced using the new 
normalizing method was not significantly different from data produced using the old method of 
data quantification (Figure 3.29). In this experiment, 6 and 14 kPa gels without cells had 
significantly more rhodamine dextran than gels with cells, as would be expected (Figure 3.30). In 
addition, an ANOVA showed an increasing trend in permeability with gel stiffness (p = 0.03), 
which is consistent with the literature (Figure 3.31).  A Tukey-Kramer post hoc test showed a 
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statistically significant increase in gel fluorescent intensity in 29 kPa samples compared to the 6 
kPa samples only (p = 0.035).  
Because the additional normalization to the FITC dextran required additional time with 
no benefit, FITC normalization was not used for the rest of the experiments. FITC dextran was 
included in the gels for future experiments because it provided a clear indicator of gel location. 
This was useful in determining the relative locations of the gel, cell, and rhodamine dextran 
liquid layers.  
 
 
Figure 3.28. Images obtained for samples of all three stiffnesses treated with 10 kDa 
dextran both with and without cell monolayers showing an increase in fluorescence 
intensity on stiffer PA gels containing a cell monolayer. Each sample was incubated with 10 
µM 10 kDa rhodamine dextran for 5 minutes prior to confocal imaging with 20x lens. Each 
image was converted from xy to xz plane and compressed based on average pixel intensity. 
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Figure 3.29. No improvement was seen between the new FITC normalization method when 
compared to the old method of not normalizing to the FITC. Intensity was normalized to 
liquid layer. n = 2. 
 
 
Figure 3.30. Statistically significant decrease in permeability was measured in 6 kPa and 14 
kPa PA gels containing a cell layer when compared to the same stiffness gels without a cell 
layer. Intensity was normalized to liquid layer. n = 2. # p < 0.05 * p < 0.01. 
 
67 
 
 
Figure 3.31. ANOVA showed an increasing trend in cell permeability on gels of increasing 
stiffness (p = 0.03). Intensity was normalized to liquid layer and samples without cells. n = 2. # p 
< 0.05 compared to 6 kPa using Tukey-Kramer Post hoc test. 
 
 The results of this analysis indicate that the further assay development increased assay 
sensitivity and decreased variability enough to produce significant and repeatable results.  
 
3.3.5 Final Assay Format: TNF-α induced Endothelial Monolayer Permeability on Substrates of 
Varying Stiffness using 10 kDa Dextran 
From the data obtained through the sensitivity phase of assay development, the final 
assay parameters are as follows:  
 5 µL of gel solution with 10 µM 40 kDa FITC dextran was used to make the PA gels 
 20 µL of 10 µM 10 kDa rhodamine dextran was incubated with samples for 5 minutes to 
measure permeability 
 Rhodamine and FITC dextrans were sequentially imaged to insure no cross fluorescence 
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 Fluorescence was quantified using the FITC images to determine the gel location 
 
Endothelial cell monolayers were treated with thrombin (positive control, 10 unit/mL, 30 
minutes) on all three stiffness gels. Four samples were imaged for each condition and each 
experiment was run in duplicate to confirm consistent results (Figure 3.32). Gel fluorescent 
intensity increased 42%, 63% and 71% (p < 0.5) with treated cells on 6kPa, 14kPa and 29kPa 
respectively (Figure 3.33). In addition, a two-way ANOVA indicated that there was a significant 
difference among stiffness (p < 0.001) and a significant interaction between stiffness and 
thrombin treatment (p = 0.04). 
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Figure 3.32. Data obtained for samples treated with 10 unit/mL thrombin on PA gels of 
varying stiffness showing an increase in fluorescence within the gel for samples treated 
with thrombin and an interaction between treatment and stiffness. Each sample contained a 
confluent monolayer of PAECs on a 6, 14 or 29 kPa PA gel. Samples were incubated with 10 
µM 10 kDa rhodamine dextran for 5 minutes prior to confocal imaging with 20x lens. Each 
image was converted from xy to xz plane and compressed based on average pixel intensity. 
Intensity was normalized to liquid layer and samples without cells. n = 4. # p < 0.05. * p < 0.01. 
** p < 0.01. 
 
 
Figure 3.33. Gel fluorescent intensity increased with thrombin treatment on 6, 14, and 29 
kPa PA gels. Intensity was normalized to liquid layer and samples without cells. n = 4. # p < 
0.05. * p < 0.01. ** p < 0.01. 
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 Once the assay detected an increase in permeability with the positive control, TNF-α 
effects were then analyzed on all three stiffness gels. Treated samples were incubated with 10 
ng/mL TNF-α for three hours. Four samples were imaged for each condition and each 
experiment was run in duplicate to confirm consistent results (Figure 3.34). Gel fluorescent 
intensity increased 37%, 60% and 50% (p < 0.5) with treated cells on 6kPa, 14kPa and 29kPa 
respectively (Figure 3.35). In addition, a two-way ANOVA indicated a significant difference 
among stiffnesses (p = 0.02); however, the interaction between stiffness and treatment was not 
statistically significant (p = 0.21). This may be due to the variability in the experiments.  
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Figure 3.34. Data obtained for samples treated with 10 ng/mL TNF-α on PA gels of varying 
stiffness showing an increase in fluorescence within the gel for samples treated with TNF-α, 
however no interaction between treatment and stiffness was observed. Each sample 
contained a confluent monolayer of PAECs on a 6, 14 or 29 kPa PA gel. Samples were incubated 
with 10 µM 10 kDa rhodamine dextran for 5 minutes prior to confocal imaging with 20x lens. 
Each image was converted from xy to xz plane and compressed based on average pixel intensity. 
Intensity was normalized to liquid layer and samples without cells. n = 4. # p < 0.05. * p < 0.01. 
** p < 0.01. 
 
 
Figure 3.35. Gel fluorescent intensity increased with TNF-α treatment on 6, 14, and 29 kPa 
PA gels. Intensity was normalized to liquid layer and samples without cells. n = 4. # p < 0.05. * 
p < 0.01. ** p < 0.001. 
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The 6kPa data was noted to be variable between the two experiments and was repeated to 
confirm the data. Treated samples were incubated with 10 ng/mL TNF-α for three hours. Four 
samples were imaged for each condition and the experiment was run in duplicate to confirm 
consistent results (Figure 3.36). Gel fluorescent intensity increased 47% (p < 0.5) with treated 
cells on 6kPa (Figure 3.37). With the updated results for the 6kPa data, a two-way ANOVA 
indicated no significant difference among stiffnesses (p = 0.13) or the interaction between 
stiffness and treatment (p = 0.60). This may be due to varying factors between each experiment 
or may indicate that this simplistic model is missing a key factor relevant for the in vivo 
condition. 
 
6 kPa 
 
 
 
 
 
 
 
 
Figure 3.36. Data obtained for samples treated with 10 ng/mL TNF-α on PA gels of 6 kPa 
stiffness showing an increase in fluorescence within the gel for samples treated with TNF-α, 
however no interaction between treatment and stiffness was observed. Each sample 
contained a confluent monolayer of PAECs on a 6 kPa PA gel. Samples were incubated with 10 
µM 10 kDa rhodamine dextran for 5 minutes prior to confocal imaging with 20x lens. Each 
image was converted from xy to xz plane and compressed based on average pixel intensity. 
Intensity was normalized to liquid layer and samples without cells. n = 4. ** p < 0.01. 
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Figure 3.37. Gel fluorescent intensity increased with TNF-α treatment on 6, 14, and 29 kPa 
PA gels. Intensity was normalized to liquid layer and samples without cells. n = 4. # p < 0.05. * 
p < 0.01. ** p < 0.001. 
 
3.4 Discussion 
 The decreased dextran diffusion into the stiffer gels is a result of the increased 
crosslinking in the stiffer gels which contributes to the increased stiffness. The difference in 
dextran diffusion on the different stiffness gels can affect the gradient driving the permeability 
process which could in turn affect the results obtained. All samples were normalized to gels of 
their corresponding stiffness containing no cell layer to attempt to account for this difference in 
diffusion. Calculating the diffusion coefficient for each gel stiffness and developing a model of 
the diffusion into the gel could additionally reveal what is happening in this assay. In addition, 
because there is a lack of diffusion into the stiffer gels, a buildup of dextran at the gel interface 
could reduce the concentration gradient across the system reducing the drive of dextran across 
the cell monolayer.  
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 In addition, there are some limitations present in this simplified in vitro model of 
endothelial permeability which may have an effect on the resulting data and explain why the 
increase in permeability is not clearly seen. Endothelial cells are the only cell type present in this 
model, therefore the effect of smooth muscle cell co-culture through mechanical or chemical 
stimuli are not taken into account. In addition, polyacrylamide gels are not ideal to mimic 
substrate stiffness and cell adhesion was noted to be variable. While the time point selected for 
treatment were supported by the literature, only one time point was assessed in this assay which 
may not full demonstrate TNFα interactions with substrate stiffness. In addition, the size of the 
dextran molecules used in this assay are smaller than the molecules involved with the buildup of 
atherosclerotic plaque.  
 
3.5 Conclusion 
Endothelial monolayer permeability was successfully measured on PA gels using a 
fluorescently labeled Dextran assay. First, the positive control thrombin showed increased gel 
fluorescent intensity as compared to control, indicating increased endothelial monolayer 
permeability. Endothelial monolayer permeability also increased on all three stiffness gels after 3 
hour TNF-α treatments. These data confirms the cell-cell junction disruption by TNF-α. In 
addition, permeability increased on substrates of increasing stiffness. The interactions between 
the substrate stiffness and TNF-α treatment was not show with this assay. Experimental 
variability may need to be further decreased or model complexity may need to be increased to 
determine if there is any interaction.  
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4. CONCLUSION AND FUTURE WORK 
 
4.1 Conclusions 
 This thesis investigated the combined effects of substrate stiffness and TNF-α on 
endothelial cell monolayer permeability. The motivation for this research was to understand if 
endothelial cells respond differently to inflammatory stimuli in a stiffened vessel than they 
would in a softer vessel. While both vascular stiffness and inflammation are associated with 
hypertension, their interactions had not yet been examined. The objective of this thesis was to 
determine how vascular stiffness and inflammation may interact, thereby leading to increased 
progression of hypertension and other cardiovascular diseases. In addition, the effect of substrate 
stiffness and inflammation has implications beyond hypertension. This model can be applied to 
any cardiovascular disease which results in arterial stiffening and inflammation such as diabetes 
and high cholesterol.  
 A tissue flow chamber was designed using computer automated design (CAD) software 
and fabricated. The chamber allows researchers to apply shear stress to a mouse thoracic aorta 
and image the endothelial layer en face. Initial testing revealed an adequate seal during flow 
testing with parafilm as a tissue mimetic. Additionally, testing showed that cells within the vessel 
remained viable over a short period (3 hours) in stagnant conditions. However, additional testing 
must be done to confirm adequate shear stress and tissue viability for longer time points. 
A permeability assay was developed to successfully measure fluorescently labeled 
dextran transport through an endothelial monolayer and into polyacrylamide gels. This assay 
confirmed that endothelial permeability increases on substrates of increasing stiffness. It also 
confirmed increased permeability with thrombin treatment and a significant interaction between 
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stiffness and thrombin. Additionally, increased endothelial monolayer permeability with TNF-α 
was detected. Although stiffness compounded the increased permeability seen with thrombin 
treatment, TNF-α interactions with substrate stiffness were more subtle and did not produce 
statistically significant results.  This may be due to cell seeding variability and the inability to 
run all conditions in the same experiment. In addition, this simplified model may be missing a 
key factor present in the in vivo case which is affecting the results. 
 
4.2 Future Work 
 Further work should focus on decreasing the variability within the permeability assay to 
determine if TNF-α induced permeability does increase with substrate stiffness. In addition, the 
effect of substrate stiffness on other endothelial cell responses to TNF-α, such as nitric oxide 
production, as well as in vivo or ex vivo studies in hypertensive animals or arteries would 
increase the clinical relevance of these results. 
 These data can be used to understand how hypertension contributes to disease such as 
atherosclerosis and allow us to develop effective hypertensive therapies. Blocking inflammation 
maybe an effective method of decreasing the progression of hypertension and decrease the risk 
of developing additional cardiovascular complications. Clinically, the measurement of arterial 
stiffness and level of inflammation combined can indicate the severity of the disease and 
determine how aggressively the patient should be treated.  
Additional testing on the tissue flow chamber should be done to confirm its ability to 
effectively apply shear stress to the endothelial monolayer and maintain cell viability for longer 
periods of time. Advancements in magnet encapsulation within the chamber to reduce any 
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cytotoxic effects could be approached. Scaling of this device could also be performed to 
potentially incorporate other vessel sizes or other animal species.  
In addition, this device could be used to measure endothelial permeability in a more 
physiologically relevant tissue structure with a greater level of control over variables which 
could affect endothelial function. Mouse models heterozygous for the elastin gene (Eln +/-) can 
be generated. Eln +/- mice have thinner elastic lamella and an increased number of SMC layers 
compared to wild type mice which results in a stiffer vessel (Li et al., 1998). The vessels of these 
Eln +/- mice can be used as an ex vivo model for determining the effects of substrate stiffness on 
endothelial layer permeability. In addition, treating the endothelial layer with TNF-α will allow 
the combined effects of substrate stiffness and TNF-α on endothelial cells to be evaluated. 
Permeability can be assessed using the ex vivo tissue chamber by flowing a fluorescently 
labeled dextran through the endothelial path of the chamber. Evaluation of endothelial 
permeability could possibly be measure through fluorescent imaging, histological staining of the 
tissue, or homogenization of the tissue to determine the amount of fluorescent dextran present in 
the vessel after a period of time. In addition, samples of the smooth muscle cell media could also 
indicate how much dextran was able to diffuse through the entire vessel.  
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